Sunday, June 29, 2008

Rosacea News June 2008

Rosacea News June 2008

1. rosacea sufferers less interested in alternative medicine

According to this recently published short correspondence, rosacea sufferers are much less likely to use complementary and alternative medicine compared to sufferers of psoriasis and other dermatological conditions. Whilst the reason is not clear, it appears one reason could be that sufferers are happy with the efficacy of their current treatment. The majority of patients felt that the complementary and alternative therapies were less helpful …


2. sensitive skin on your hands, feet and scalp too ?

The common wisdom about rosacea is that is only occurs around the flush zones on your face. A recent paper challenged this idea with a case study of a patient who had rosacea lesions on his arm, and upper chest area. Another related recent short paper titled Sensitive skin is not limited to the face, that has the conclusion that sensitive skin is …


3. NRS wants your feedback on Research !

The NRS Blog has a new entry today where they are asking for your feedback on the direction of future rosacea research. The NRS have put their Reader Survey (part of their Rosacea Review publication) online for the first time.

4. Allergan buys Aczone, has plans for rosacea targeting ?

OK this story is getting so much coverage in the online press that I thought I should cover it here too. Allergan is buying the topical dapsone product called Aczone for $150m. From: Allergan Announces Agreement to Acquire Aczone(R) Gel 5% …


5. Sansrosa gel vs. eyes drops absorption trial details posted

The Clinical Trial register is showing details for the bio-availabilty trial for COL-118/Sansrosa. This Phase 2 trial aims to compare the amount of the active ingredient that is bio-available when the newly formulated gel is used on rosacea skin, and when used as eye drops.

This announcement appears to be the extra trial asked for by the FDA who are concerned that …

Monday, June 16, 2008

Rosacea News May 2008

Rosacea News May 2008

1. combining Azithromycin with Protopic (tacrolimus) topical

This paper details a somewhat exotic combination therapy: oral azithromycin and topical tacrolimus. It offers an alternative to the more common doxycycline + metrogel combination. The authors mention that this is not a first line therapy; "a combination of oral azithromycin and …

2 Flushing: it’s all in your nerves and emotions

In November 2006 I blogged about taking part in some research at Murdoch University investigating the relationship between stress and the flushing of rosacea. Recently the researcher, Daphne Su, has thanked the trial participants by circulating a summary document. The research has been written up as a thesis so this summary was a short description of some the …

3. Low Level Light Therapy details posted

TP has posted an update to her Low Level Light Therapy- an overview thread at the Rosacea Support Forum.

This recent update is from a document called Cellular Mechanisms of Low-Power Laser Therapy.

Thanks for the update TP. This thread is worth a read for those interested in Low Level Light Therapy (LLLT) such as LEDs, infrared, red and blue light.

4. Marketing company seeks interviews in Houston, TX

Schlesinger Associates are looking for rosacea patients on Friday June 13 2008, to attend an interview for an hour at their Galleria Area location in Houston TX. Their address is 1455 West Loop South, Suite 500. …

5. Google Health Launches, rosacea is included as a condition

Google has been talking for a while about their push into health services. One of their stated features of Google Health is "Learn about health issues and find helpful resources: Review trusted information on diseases and conditions and learn about possible medication interactions and other topics to talk your doctors about." As part of their new offering Google Health has created some Condition References. …

6. does using a computer screen worsen rosacea symptoms ?

Rosacea sufferers sometimes bring up the topic of computer screens and indeed lighting in general as a trigger for their rosacea. Sadly there seems to be little conclusive literature available on this topic. A 1985 study in Norway, Does visual display terminal work provoke rosacea? was able to show that rosacea and seborrheic dermatitis sufferers were over represented in …

7. cathelicidins regulated by Vitamin D3

Another paper stemming from the partly NRS funded research into the role of cathelicidins and its role in rosacea. A lot of publicity and publications have resulted from Dr. Gallo’s research. This avenue of research into rosacea looks promising so lets hope that more resources target involved with this area of research. Those that interested in the role that Vitamin D3 play …

8. metrogel also works for seborrheic dermatitis

This paper found that 0.75% metrogel worked just as well as ketoconazole 2% cream in treating SD. The study found that both were able to offer significant improvement with similar side effects. The authors suggest that because there is so little evidence of anti fungal activity of metronidazole, it is difficult to speculate …

9. Sebclair for seborrheic dermatitis

This recently published paper investigates the effectiveness of a `novel steroid-free cream containing multiple active ingredients’, called Sebclair to treat facial seborrheic dermatitis.

This product sounds quite interesting for rosacea and rosacea/SD sufferers. Little information about Sebclair is currently available on the internet.

10. SIBO eradication clears rosacea: are you serious ?

This sort of abstract just make me shake my head. If you read quickly you will think that this abstract suggests that Small Intestinal Bacterial Overgrowth (SIBO) causes rosacea. What this abstract is saying that is that rosacea sufferers seem to have a higher incidence of SIBO than non rosacea sufferers. The secondary result is that eliminating SIBO clears rosacea. Well that is no surprise …

11. Pycnogenol Redness Reducing Serum: any reviews ?

Pycnogenol® is the patented trade name for a water extract of the bark of the French maritime pine ( Pinus pinaster  ssp.  atlantica ), which is grown in coastal south-west France. Pycnogenol® contains oligomeric proanthocyanidins (OPCs) as well as several other bioflavonoids: catechin, epicatechin, phenolic fruit acids (such as ferulic acid and caffeic acid), and taxifolin. Procyanidins are oligometric catechins found at high concentrations in red wine, grapes, cocoa, cranberries, apples, and some supplements such as Pycnogenol®.